Abstract
Proteolysis-targeting chimeras (PROTACs) are bifunctional molecules that bind and recruit an E3 ubiquitin ligase to a targeted protein of interest, often through the utilization of a small molecule inhibitor. To expand the possible range of kinase targets that can be degraded by PROTACs, we sought to develop a PROTAC utilizing a hydrocarbon-stapled peptide as the targeting agent to bind the surface of a target protein of interest. In this study, we describe the development of a proteolysis-targeting chimera, dubbed Stapled Inhibitor Peptide - PROTAC or StIP-TAC, linking a hydrocarbon-stapled peptide with an E3 ligase ligand for targeted degradation of Protein Kinase A (PKA). This StIP-TAC molecule stimulated E3-mediated protein degradation of PKA, and this effect could be reversed by the addition of the proteasomal inhibitor MG-132. Further, StIP-TAC treatment led to a significant reduction in PKA substrate phosphorylation. Since many protein targets of interest lack structural features that make them amenable to small molecule targeting, development of StIP-TACs may broaden the potential range of protein targets using a PROTAC-mediated proteasomal degradation approach.
MeSH terms
-
Cyclic AMP-Dependent Protein Kinases* / metabolism
-
Humans
-
Peptides* / chemistry
-
Peptides* / metabolism
-
Peptides* / pharmacology
-
Phosphorylation / drug effects
-
Proteasome Endopeptidase Complex / metabolism
-
Proteolysis* / drug effects
-
Ubiquitin-Protein Ligases / metabolism
Substances
-
Cyclic AMP-Dependent Protein Kinases
-
Peptides
-
Ubiquitin-Protein Ligases
-
Proteasome Endopeptidase Complex